Craddock, C., Versluis, J., Labopin, M., Socie, G., Huyn, A., Deconinck, E., . . . Nagler, A. (2016). Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Leukaemia (AML) in First CR: A survey from HOVON-SAKK and the acute leukaemia working party of the EBMT. American Society of Hematology.
Cytowanie według stylu Chicago (wyd. 17)Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.
Cytowanie według stylu MLA (wyd. 9)Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.